[A clinico-experimental study of the anticoagulant nafarin].
D000328:Adult; D000368:Aged; D000818:Animals; D001780:Blood Coagulation Tests; D003327:Coronary Disease / Q000188:drug therapy*; D004285:Dogs; D005164:Factor IX / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005260:Female; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D011517:Prothrombin Time; D011817:Rabbits; D051381:Rats; D013916:Thrombelastography; D013917:Thrombin / Q000494:pharmacology; D014859:Warfarin / Q000627:therapeutic use*
D014859:Warfarin; D005167:Factor VII; D005164:Factor IX; D005170:Factor X; D006493:Heparin; D013917:Thrombin
Kliniko-éksperimental'noe izuchenie antikoagulianta nafarina.